Program Information
Pharmacy-based Point-of-Care Test & Treat National Certificate Program
ACPE Universal Activity #0112-0000-22-200-B04-P/T
Activity Type: Practice-based
Target Audience: Pharmacists and pharmacy technicians in all practice settings
Release Date: January 3, 2022
Expiration Date: January 3, 2025
Contact Hours: 20.0
Learning Objectives
At the completion of this activity, the pharmacist will be able to:
- Identify opportunities for expanding patient-centered services in pharmacy settings, using point-of-care testing and treatment.
- Discuss the value and limitations of patient reported symptoms, medical history, and drug allergies.
- Describe and perform the following physical assessments, when appropriate to patient care: Blood Pressure, Pulse, Respiratory Rate, Oxygenation, and Cervical Lymph Node Inspection
- Describe and perform the following specimen collections used in point of care testing: Throat swab, and Nasal swab
- Identify characteristics of exemplar infectious diseases (e.g. influenza, Group A Streptococcus, Human Immunodeficiency Virus, Hepatitis C, Coronaviruses) regarding: Causative agents, Transmission, Immunizations, Symptoms and Presentation, Appropriate treatment, Point-of-Care testing.
- Define and contrast the following terms as they relate to point-of-care testing in pharmacies: CLIA, CLIA-waived, Collaborative Agreement, Protocol, Prescribe, Diagnose.
- Explain the value and limitations of Point-of-Care Tests, including rapid diagnostic tests, and list the steps a pharmacist can take to improve test performance.
- Apply all information to patient-specific cases based on common pharmacy-based patient interaction.
At the completion of this activity, the pharmacy technician will be able to:
- Identify opportunities for expanding patient-centered services in pharmacy settings, using point-of-care testing and treatment.
- Discuss the value and limitations of patient reported symptoms, medical history, and drug allergies.
- Describe and perform under the supervision of a pharmacist the following physical assessments, when appropriate to patient care: Blood Pressure, Pulse, Respiratory Rate, Oxygenation, and Cervical Lymph Node Inspection
- Describe and perform the following specimen collections used in point of care testing: Throat swab, and Nasal swab
- Identify characteristics of exemplar infectious diseases (e.g. influenza, Group A Streptococcus, Human Immunodeficiency Virus, Hepatitis C, Coronaviruses) regarding: Causative agents, Transmission, Immunizations, Symptoms and Presentation, and Point-of-Care testing.
- Define and contrast the following terms as they relate to point-of-care testing in pharmacies: CLIA, CLIA-waived, Collaborative Agreement, Protocol, Prescribe, Diagnose.
- Explain the value and limitations of Point-of-Care Tests, including rapid diagnostic tests.
Target Audience
This course provides pharmacists, pharmacy technicians, and student pharmacists with the skills necessary to develop a testing program for influenza, Group A streptococcus, HIV, hepatitis C, and Coronavirus.
Claiming Credit
Continuing pharmacy education (CPE) credit will be awarded for the certificate training course only. This is a Certificate Program and is primarily constructed to instill, expand or enhance practice competencies through the systematic achievement of specified knowledge, skills, attitudes and performance behaviors.
Successful completion of the live/virtual seminar component involves passing the final exam with a grade of 70 percent or higher and demonstrating proficiency in diagnostic testing techniques. Successful completion of the self-study component involves passing the self-study assessment questions with a grade of 70 percent or higher. Credit is only awarded for completion of the entire 20 contact hour program. Credit must be claimed within 30 days of completing the program (no exceptions). Attendance and participation are required before obtaining CPE credit. Partial credit will not be awarded.
CPE Monitor, is a national, collaborative effort by the Accreditation Council for Pharmacy Education (ACPE) and the National Association of Boards of Pharmacy (NABP) to provide an electronic system for pharmacists and pharmacy technicians to track their completed PCE credits. This system allows pharmacists and pharmacy technicians to log into a comprehensive electronic profile to access information about their completed CPE. All ACPE-accredited providers will be required to use this system. CPE Statements of Credit will no longer be mailed.
All continuing education credits provided by the Michigan Pharmacists Association (MPA) will be uploaded to the CPE Monitor by Lecture Panda. Lecture Panda is a platform that MPA utilizes to submit your CPE credits. You can access all certificate program materials – learning modules, PowerPoint slides, additional learning materials, assessments, and evaluations in this platform. As soon as you complete your evaluation and other instructions, it is validated and automatically sent to CPE Monitor for accreditation so there is no wait time to receive credit. After CPE credits are processed by ACPE and NABP, pharmacists and pharmacy technicians are able to log into their NABP e-Profile and view all of their completed ACPE-accredited CPE credit.
In order to process CPE credits, please provide Lecture Panda with your correct NABP e-Profile ID number and your birth month and day (MMDD format). The NABP e-Profile ID number is currently a 6-digit number, and it is not your license number or NPI number. If you need to verify the number or have not yet registered for one, visit www.MyCPEMonitor.net as soon as possible.
Michigan Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
Additional Information
Welcome Page
Agenda
Developer Bios
Upcoming Trainings
Host a Training
Disclaimers
Train the Trainer